eMurmur ID vs ElucidVivo A.3
AI Verdict
Choose eMurmur ID if…
Choose eMurmur ID if your primary need is a rapid, AI-assisted screening and classification of heart murmurs at the point of care, utilizing existing electronic stethoscopes. This tool is ideal for general practitioners, pediatricians, or cardiologists seeking real-time decision support for initial heart sound assessments and patient triaging.
View eMurmur ID →Choose ElucidVivo A.3 if…
Choose ElucidVivo A.3 if you require advanced, quantitative analysis of arterial plaque composition and stability from CT angiography to refine atherosclerosis patient stratification. This system is best suited for cardiologists, radiologists, and vascular surgeons who need detailed insights into plaque characteristics for optimizing treatment decisions and managing cardiovascular risk.
View ElucidVivo A.3 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | eMurmur ID | ElucidVivo A.3 |
|---|---|---|
| Deployment | Cloud, Mobile, API integration | Cloud and on-premise secure deployment. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur IDeMurmur ID (Tool A) offers a mobile app and web portal for recording and reviewing heart sounds, providing real-time feedback within seconds and operating with common third-party electronic stethoscopes. This mobile-first approach and immediate feedback make it highly accessible and user-friendly for a broader range of healthcare providers in various clinical settings. ElucidVivo A.3 (Tool B), while integrated with PACS/EMR, is a specialized software application for detailed imaging analysis, suggesting a more complex interface tailored for imaging specialists.
Clinical Value
ElucidVivo A.3ElucidVivo A.3 (Tool B) provides quantitative analysis of arterial plaque composition and stability from CT angiography, validated against ground-truth histology, and can derive fractional flow reserve (FFRct). This offers a highly precise and impactful contribution to atherosclerosis patient stratification and treatment optimization for a life-threatening condition. eMurmur ID (Tool A) offers valuable decision support for detecting and classifying heart murmurs, which is a common diagnostic challenge, but ElucidVivo A.3's depth of analysis for a critical disease offers a more profound clinical impact.
Pricing & Value
TieBoth eMurmur ID (Tool A) and ElucidVivo A.3 (Tool B) state 'contact vendor' or 'contact for pricing' for their pricing information. Without transparent pricing details or specific case studies on return on investment, it is not possible to compare their value propositions effectively.
Enterprise Readiness
eMurmur IDeMurmur ID (Tool A) explicitly states it is HIPAA compliant, has a Business Associate Agreement (BAA) available, is FDA cleared, and offers flexible deployment options including mobile, cloud (SaaS), on-premise, and hybrid. ElucidVivo A.3 (Tool B) is FDA cleared, but its HIPAA compliance and BAA availability are only implied or 'expected,' and its deployment options are less explicitly detailed beyond being a 'software application' that integrates with PACS/EMR. Tool A's explicit compliance and deployment flexibility demonstrate stronger enterprise readiness.
Innovation
ElucidVivo A.3ElucidVivo A.3 (Tool B) demonstrates significant innovation by providing AI-powered quantitative analysis of arterial plaque composition and stability from CT angiography, validated against ground-truth histology, and deriving FFRct. This offers non-invasive 'virtual histology' and functional assessment, pushing the boundaries of cardiovascular imaging. eMurmur ID (Tool A) is innovative in applying AI to mobile auscultation with third-party stethoscopes for real-time murmur detection, but ElucidVivo A.3's detailed, histology-validated plaque characterization represents a more advanced and disruptive diagnostic capability.
Support & Docs
eMurmur IDeMurmur ID (Tool A), operating under CSD Labs GmbH, provides a general feedback and support email address and mentions a vulnerability disclosure policy on its website, indicating a structured approach to customer support. For ElucidVivo A.3 (Tool B), web searches did not yield explicit support contact information or dedicated documentation portals, making it difficult to assess the availability and quality of its support and documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | eMurmur ID | ElucidVivo A.3 |
|---|---|---|
| Tool Name | eMurmur ID | ElucidVivo A.3 |
| Company | CSD Labs GmbH | Elucid Bioimaging |
| Primary Function | AI-powered mobile and cloud solution for detecting and classifying heart murmurs using a third-party electronic stethoscope, providing decision support for healthcare providers. | FDA-cleared AI-powered medical image analysis system that provides quantitative analysis of arterial plaque composition and stability from CT angiography. It assists physicians in atherosclerosis patient stratification and optimizes treatment decisions by offering detailed visualization and measurement of plaque characteristics validated against histology. |
| Tagline | AI-powered & telehealth-enabled | AI-Powered Plaque Analysis for Cardiovascular Care |
| Key AI Application | AI-based analytics for heart murmur detection and classification | AI-powered quantitative analysis of arterial plaque composition and stability from CT angiography |
Videos
Demos, reviews, and walkthroughs featuring eMurmur ID and ElucidVivo A.3.